Valuation : Eckert & Ziegler SE

Market Cap 80Cr 93Cr 75Cr 69Cr 128.26Cr 8.79TCr 129.27Cr 888.48Cr 346.01Cr 4.49TCr 349.31Cr 341.69Cr 14TCr P/E 2026 *
15.6x
P/E 2027 * 14.8x
Enterprise Value 68Cr 80Cr 64Cr 59Cr 109.7Cr 7.52TCr 110.57Cr 759.97Cr 295.96Cr 3.84TCr 298.79Cr 292.27Cr 12TCr EV / Sales 2026 *
2.15x
EV / Sales 2027 * 1.98x
Free-Float
67.36%
Yield 2026 *
1.64%
Yield 2027 * 1.68%
1 day+2.56%
1 month+2.56%
Current year 12.29
Extreme 12.293
14.67
1 year 12.29
Extreme 12.293
14.67
3 years 12.29
Extreme 12.293
14.67
5 years 12.29
Extreme 12.293
14.67
10 years 12.29
Extreme 12.293
14.67
Manager TitleAgeSince
Chief Executive Officer 59 07/06/2023
Chief Tech/Sci/R&D Officer - 01/01/2025
Chief Operating Officer 59 01/01/2025
Director TitleAgeSince
Chairman 57 07/06/2023
Director/Board Member 66 01/01/2014
Director/Board Member 58 01/01/2017
Change 5-day change 1-year change 3-year change Capi.($)
+2.56%-.--% - - 92Cr
-0.49%+0.16%+25.12%-34.00% 1.76TCr
+1.44%-3.73%-33.99%+58.58% 161.01Cr
+0.31%-1.99%-23.96%+17.27% 92Cr
-0.14%-6.57%-50.69%-83.34% 96Cr
+0.27%+0.22%+59.66%-7.12% 78Cr
-1.58%-2.86%-33.86%-47.32% 68Cr
+1.79%+11.94%-37.35%-45.75% 61Cr
-0.38%+8.64%-31.58%-32.77% 49Cr
-2.81%-3.18%+69.02%+41.21% 43Cr
Average +0.10%+0.90%-6.40%-14.80% 267.83Cr
Weighted average by Cap. -0.20%+0.46%+13.79%-26.25%

Financials

2026 *2027 *
Net sales 32Cr 37Cr 30Cr 27Cr 51Cr 3.49TCr 51Cr 353Cr 137.47Cr 1.79TCr 138.78Cr 135.76Cr 5.75TCr 34Cr 40Cr 32Cr 29Cr 55Cr 3.76TCr 55Cr 379.45Cr 147.77Cr 1.92TCr 149.18Cr 145.93Cr 6.18TCr
Net income 5.17Cr 6.01Cr 4.85Cr 4.44Cr 8.28Cr 567.8Cr 8.35Cr 57Cr 22Cr 290.17Cr 23Cr 22Cr 934.52Cr 5.31Cr 6.17Cr 4.98Cr 4.56Cr 8.51Cr 583.23Cr 8.57Cr 59Cr 23Cr 298.06Cr 23Cr 23Cr 959.93Cr
Net Debt -12Cr -13Cr -11Cr -9.94Cr -19Cr -1.27TCr -19Cr -128.51Cr -50Cr -649.97Cr -51Cr -49Cr -2.09TCr -12Cr -14Cr -11Cr -11Cr -20Cr -1.35TCr -20Cr -135.99Cr -53Cr -687.81Cr -53Cr -52Cr -2.22TCr
Logo Eckert & Ziegler SE
Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Employees
1,105
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
12.79EUR
Average target price
21.60EUR
Spread / Average Target
+68.88%

Annual profits - Rate of surprise